NextGen Health reviews
3 independent lab tests across 1 product · 99.8% average purity
- 3 HPLC samples across 1 products
- Catalog avg purity 99.8%
- ngpeptide.com
- Independent testing, no pay-to-rank
Boren Health independently tests products and verifies reviews. Public methodology, no pay-to-rank.
Track NextGen Health
Create a free account to save this vendor, get alerts for new lab tests, and watch price changes.
What the testing shows
Across 3 measured samples from NextGen Health, 1 came in more than 5% under the quantity on the label (33%). Purity across 3 readings ran from 99.68% to 99.81%, median 99.8%. Samples span Jun 2025 to Nov 2025.
- Under label
- 1/3
- Median purity
- 99.8%
- Latest sample
- Nov 2025
- Ships from
- United States
more than 5% short
99.68%–99.81% range
first tested Jun 2025
per vendor listing
Lab testing results
Independent results across 1 product.
Tested products
| Product | Grade | Tests | Avg | Range | Latest | Price | $/mg |
|---|---|---|---|---|---|---|---|
| Tirzepatide | AGREAT | 3 | 100.0% | 99.7% – 99.8% | 11/4/2025 | — | — |
Individual lab tests
Date
11/4/2025
Purity
99.68%
Quantity
10 mg → 9.95 mg
Lab
Krause Analytical
Vial
No Label / Silver Crimp / White Cap
Date
6/29/2025
Purity
99.8%
Quantity
30 mg → 27.3 mg
Lab
Krause Analytical
Vial
No Label / Copper Crimp / Clear Cap
Date
6/11/2025
Purity
99.81%
Quantity
20 mg → 19.2 mg
Lab
Krause Analytical
Vial
No Label / Silver Crimp / Grey Cap
| Product | Date | Score | Purity | Quantity | Lab | COA |
|---|---|---|---|---|---|---|
| TirzepatideNo Label / Silver Crimp / White Cap | 11/4/2025 | 10.0 | 99.68% | 10 mg → 9.95 mg | Krause Analytical | View |
| TirzepatideNo Label / Copper Crimp / Clear Cap | 6/29/2025 | 10.0 | 99.8% | 30 mg → 27.3 mg | Krause Analytical | View |
| TirzepatideNo Label / Silver Crimp / Grey Cap | 6/11/2025 | 10.0 | 99.81% | 20 mg → 19.2 mg | Krause Analytical | View |
About NextGen Health
Finnrick has tested 3 samples from NextGen Health across 1 products.